219 related articles for article (PubMed ID: 14527677)
1. Enhanced in vivo delivery of antisense oligonucleotides to restore dystrophin expression in adult mdx mouse muscle.
Wells KE; Fletcher S; Mann CJ; Wilton SD; Wells DJ
FEBS Lett; 2003 Sep; 552(2-3):145-9. PubMed ID: 14527677
[TBL] [Abstract][Full Text] [Related]
2. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.
Alter J; Lou F; Rabinowitz A; Yin H; Rosenfeld J; Wilton SD; Partridge TA; Lu QL
Nat Med; 2006 Feb; 12(2):175-7. PubMed ID: 16444267
[TBL] [Abstract][Full Text] [Related]
3. Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers.
Williams JH; Sirsi SR; Latta DR; Lutz GJ
Mol Ther; 2006 Jul; 14(1):88-96. PubMed ID: 16488666
[TBL] [Abstract][Full Text] [Related]
4. Peptide conjugation of 2'-O-methyl phosphorothioate antisense oligonucleotides enhances cardiac uptake and exon skipping in mdx mice.
Jirka SM; Heemskerk H; Tanganyika-de Winter CL; Muilwijk D; Pang KH; de Visser PC; Janson A; Karnaoukh TG; Vermue R; 't Hoen PA; van Deutekom JC; Aguilera B; Aartsma-Rus A
Nucleic Acid Ther; 2014 Feb; 24(1):25-36. PubMed ID: 24320790
[TBL] [Abstract][Full Text] [Related]
5. Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy.
Takeshima Y; Yagi M; Wada H; Ishibashi K; Nishiyama A; Kakumoto M; Sakaeda T; Saura R; Okumura K; Matsuo M
Pediatr Res; 2006 May; 59(5):690-4. PubMed ID: 16627883
[TBL] [Abstract][Full Text] [Related]
6. Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles.
Pichavant C; Chapdelaine P; Cerri DG; Bizario JC; Tremblay JP
Hum Gene Ther; 2010 Nov; 21(11):1591-601. PubMed ID: 20553115
[TBL] [Abstract][Full Text] [Related]
7. Gene delivery to dystrophic muscle.
Wells KE; McMahon J; Foster H; Ferrer A; Wells DJ
Methods Mol Biol; 2008; 423():421-31. PubMed ID: 18370219
[TBL] [Abstract][Full Text] [Related]
8. Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse.
Lu QL; Mann CJ; Lou F; Bou-Gharios G; Morris GE; Xue SA; Fletcher S; Partridge TA; Wilton SD
Nat Med; 2003 Aug; 9(8):1009-14. PubMed ID: 12847521
[TBL] [Abstract][Full Text] [Related]
9. Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping.
Goyenvalle A; Vulin A; Fougerousse F; Leturcq F; Kaplan JC; Garcia L; Danos O
Science; 2004 Dec; 306(5702):1796-9. PubMed ID: 15528407
[TBL] [Abstract][Full Text] [Related]
10. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice.
Benchaouir R; Meregalli M; Farini A; D'Antona G; Belicchi M; Goyenvalle A; Battistelli M; Bresolin N; Bottinelli R; Garcia L; Torrente Y
Cell Stem Cell; 2007 Dec; 1(6):646-57. PubMed ID: 18371406
[TBL] [Abstract][Full Text] [Related]
11. Functionalized PEG-PEI copolymers complexed to exon-skipping oligonucleotides improve dystrophin expression in mdx mice.
Sirsi SR; Schray RC; Guan X; Lykens NM; Williams JH; Erney ML; Lutz GJ
Hum Gene Ther; 2008 Aug; 19(8):795-806. PubMed ID: 18647087
[TBL] [Abstract][Full Text] [Related]
12. Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides.
Echigoya Y; Yokota T
Nucleic Acid Ther; 2014 Feb; 24(1):57-68. PubMed ID: 24380394
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal administration of phosphorothioate antisense oligodeoxynucleotide against splicing enhancer sequence induced exon skipping in dystrophin mRNA expressed in mdx skeletal muscle.
Takeshima Y; Yagi M; Wada H; Matsuo M
Brain Dev; 2005 Oct; 27(7):488-93. PubMed ID: 16198206
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function.
Yin H; Moulton HM; Seow Y; Boyd C; Boutilier J; Iverson P; Wood MJ
Hum Mol Genet; 2008 Dec; 17(24):3909-18. PubMed ID: 18784278
[TBL] [Abstract][Full Text] [Related]
15. A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
Yin H; Moulton HM; Betts C; Seow Y; Boutilier J; Iverson PL; Wood MJ
Hum Mol Genet; 2009 Nov; 18(22):4405-14. PubMed ID: 19692354
[TBL] [Abstract][Full Text] [Related]
16. Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle.
Gebski BL; Mann CJ; Fletcher S; Wilton SD
Hum Mol Genet; 2003 Aug; 12(15):1801-11. PubMed ID: 12874101
[TBL] [Abstract][Full Text] [Related]
17. Screening for antisense modulation of dystrophin pre-mRNA splicing.
Dickson G; Hill V; Graham IR
Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S67-70. PubMed ID: 12206799
[TBL] [Abstract][Full Text] [Related]
18. A dystrophic Duchenne mouse model for testing human antisense oligonucleotides.
Veltrop M; van Vliet L; Hulsker M; Claassens J; Brouwers C; Breukel C; van der Kaa J; Linssen MM; den Dunnen JT; Verbeek S; Aartsma-Rus A; van Putten M
PLoS One; 2018; 13(2):e0193289. PubMed ID: 29466448
[TBL] [Abstract][Full Text] [Related]
19. Electroporation of corrective nucleic acids (CNA) in vivo to promote gene correction in dystrophic muscle.
Kapsa RM; Wong SH; Quigley AF
Methods Mol Biol; 2008; 423():405-19. PubMed ID: 18370218
[TBL] [Abstract][Full Text] [Related]
20. Delivery of AAV2/9-microdystrophin genes incorporating helix 1 of the coiled-coil motif in the C-terminal domain of dystrophin improves muscle pathology and restores the level of α1-syntrophin and α-dystrobrevin in skeletal muscles of mdx mice.
Koo T; Malerba A; Athanasopoulos T; Trollet C; Boldrin L; Ferry A; Popplewell L; Foster H; Foster K; Dickson G
Hum Gene Ther; 2011 Nov; 22(11):1379-88. PubMed ID: 21453126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
